An Oncology Provider-Driven Model to Implement Germline Genetic Testing Among Diverse Patients With Advanced Prostate Cancer
Journal of Clinical Pathways · 01.02.2025 · 11 (1)
DOI: 10.25270/jcp.2025.01.02 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Pathways, online erschienen am 15.02.2025. Verfasst von Lisa Nuccio und 10 weiteren Autor:innen.
Abstract (Originalsprache)
This retrospective study examined the clinical implementation of an oncology-directed model of delivering guideline-concordant germline genetic testing in patients living with and receiving standard-of-care treatment for advanced prostate cancer. Clinical information was obtained per chart review of electronic medical records (EMRs), and biostatistics analysis was performed utilizing SAS. Of the cohort of 132 patients with prostate cancer who received germline genetic testing, most had negative test results (n = 57, 43.2%), with a smaller subset of patients found to have pathogenic or likely pathogenic (P/LP) germline variants (n = 11, 8.3%). The incidence of actionable homologous recombination repair alterations was lower than previously reported in the literature at 4.7% (n = 6). There was a low rate of alterations in autosomal dominant genes, ~6.3% (n = 8). Variants of uncertain significance were more frequent in patients who self-identified as Black compared with White and Hispanic patients. Of the patients with P/LP germline variants, 100% received follow-up care with genetic counselors. Ultimately, this study aimed to promote greater access to genetic testing and counseling for individuals with prostate cancer in an ever-changing field.
Zitieren
APA
Nuccio, L., Drabek, K., Hippalgaonkar, N., Tiwari, A., Pan, V., Hoskins, K., Ganschow, P., Maga, T., Balay, L., Tawagi, K., & Reizine, N. (2025). An Oncology Provider-Driven Model to Implement Germline Genetic Testing Among Diverse Patients With Advanced Prostate Cancer. Journal of Clinical Pathways, 11(1). https://doi.org/10.25270/jcp.2025.01.02
Vancouver
Nuccio L, Drabek K, Hippalgaonkar N, Tiwari A, Pan V, Hoskins K, et al. An Oncology Provider-Driven Model to Implement Germline Genetic Testing Among Diverse Patients With Advanced Prostate Cancer. Journal of Clinical Pathways. 2025;11(1). doi:10.25270/jcp.2025.01.02
BibTeX
@article{Nuccio2025,
author = {Nuccio, Lisa and Drabek, Kirsten and Hippalgaonkar, Neha and Tiwari, Aseem and Pan, Vivian and Hoskins, Kent and Ganschow, Pamela and Maga, Tara and Balay, Lara and Tawagi, Karine and Reizine, Natalie},
title = {An Oncology Provider-Driven Model to Implement Germline Genetic Testing Among Diverse Patients With Advanced Prostate Cancer},
journal = {Journal of Clinical Pathways},
year = {2025},
volume = {11},
number = {1},
doi = {10.25270/jcp.2025.01.02}
}
EUVIMED